53
total announcements
KRONOX.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 21 Oct 2026
Market Cap
₹741 Cr
P/E (TTM)
25.8
EPS (TTM)
₹7.73
52W Low
₹96.00
52W High
₹227.74
Dividend Yield
0.25%
Beta
0.89
Price / Book
6.3
Debt / Equity
1.4
Revenue (TTM)
₹105 Cr
Gross Margin
53.66%
Operating Margin
30.11%
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on October 14, 2026, where the Board of Directors approved the acquisition of a Plant admeasuring about 5000 Sq. meters located in a Dahej Special Economic Zone from Axiom Chemicals Private Limited.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange about the outcome of its Board Meeting held on October 14, 2026, where it approved the acquisition of a plant from Axiom Chemicals Private Limited to expand its manufacturing capacity.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has submitted a Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, as required under Regulation 74(5).
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has made disclosures under Regulation 7(2) of SEBI PIT Regulations, 2015, regarding the sale of shares by promoters Mr. Jogindersingh Jaswal, Mr. Ketan Ramani, and Mr. Pritesh Ramani, representing approximately 23.09% and 18.09% of the company's total paid-up equity share capital.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the appointment of new directors, including Executive Directors and Chief Executive Officer, and the transfer of shares from the Sellers to the Purchaser.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has appointed Mr. Sunil Malhotra as Executive Director, effective September 29, 2026.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the appointment of Mr. Dhananjay Tapasvi as Independent Director of the company, effective September 29, 2026. The company has also received an intimation from the Sellers that they have transferred the Sale Shares to the Purchaser on September 29, 2026, and the Sellers collectively hold 36,90,000 equity shares aggregating to 9.95% of the voting share capital of the Company.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the appointment of Mr. Harsh Malhotra as Executive Director of the company, effective September 29, 2026. The company has also received an intimation from the Sellers that they have transferred the Sale Shares to the Purchaser on September 29, 2026, and the Sellers collectively hold 36,90,000 equity shares aggregating to 9.95% of the voting share capital of the Company.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the appointment of Mr. Shashikant Bharuka as Chief Financial Officer of the company, effective September 29, 2026. The company has also received an intimation from the Sellers that they have transferred the Sale Shares to the Purchaser on September 29, 2026. The Sellers collectively hold 36,90,000 equity shares aggregating to 9.95% of the voting share capital of the Company and each of the Sellers along with other members of the promoter group of the Company have ceased to be members of the promoter/promoter group of the Company with effect from the completion of the Sale Transaction.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the appointment of Mr. Amit Kumar Sharma as Independent Director of the company, effective September 29, 2026. The company has also received an intimation from the Sellers that they have transferred the Sale Shares to the Purchaser on September 29, 2026, and the Sellers collectively hold 9.95% of the voting share capital of the Company.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the appointment of Mr. Suresh Kalra as Managing Director & CEO of the company, effective September 29, 2026. The company also announced the appointment of new directors, including Mr. Sunil Malhotra, Mr. Harsh Malhotra, Mr. Amit Kumar Sharma, Ms. Anuradha Suneet Maheshwari, and Mr. Dhananjay Tapasvi.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange about Agreements, including the transfer of shares from the Sellers to the Purchaser and the appointment of new directors.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Change in Director(s) of the company. The company has received an intimation from the Sellers that the Sellers have transferred the Sale Shares to the Purchaser on September 29, 2026. The Sellers collectively hold 36,90,000 equity shares aggregating to 9.95% of the voting share capital of the Company and each of the Sellers along with other members of the promoter group of the Company have ceased to be members of the promoter/promoter group of the Company. The Board has approved the appointment of new directors and Chief Executive Officer.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Cessation of Mr. Satish Kumar as Independent Director of the company w.e.f. September 29, 2026. The company has also announced the appointment of new directors, including Executive Directors and Chief Executive Officer, and non-executive independent directors.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Cessation of Mr. Krutika Negandhi as Independent Director of the company w.e.f. September 29, 2026. The company has also announced the appointment of new directors, including Executive Directors and Chief Executive Officer, and non-executive independent directors.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Cessation of Mr Mr. Jogindersingh Jaswal as Chairman & Managing Director of the company w.e.f. September 29, 2026. The company has received an intimation from the Sellers, that the Sellers have transferred the Sale Shares to the Purchaser on September 29, 2026. The board of directors of the Company has approved the appointment of new directors and the Chief Financial Officer.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Cessation of Mr. Parth Shah as Independent Director of the company w.e.f. September 29, 2026. The company has also received an intimation from the Sellers, pursuant to the provisions of Regulations 30 and 30A of the Listing Regulations, that the Sellers have transferred the Sale Shares to the Purchaser on September 29, 2026. The Board has approved the appointment of new directors and the transfer of Sale Shares.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the cessation of Mr. Ketan Ramani as Executive Director of the company, effective September 29, 2026. The company has also announced the appointment of new directors, including Mr. Suresh Kalra as Managing Director and Chief Executive Officer, and Mr. Sunil Malhotra and Mr. Harsh Malhotra as executive directors.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the cessation of Mr. Pritesh Ramani as Executive Director of the company, effective September 29, 2026. The company has also announced the appointment of new directors, including Mr. Suresh Kalra as Managing Director and Chief Executive Officer, and the transfer of shares from the sellers to the purchaser.